Annual Long Term Debt
$38.30 K
+$38.30 K+100.00%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual long term debt is $38.30 thousand, with the most recent change of +$38.30 thousand (+100.00%) on December 1, 2023.
- During the last 3 years, RNAZ annual long term debt has fallen by -$2.05 million (-98.16%).
- RNAZ annual long term debt is now -98.16% below its all-time high of $2.09 million, reached on December 31, 2020.
Performance
RNAZ Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$0.00
$0.000.00%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly long term debt is $0.00, unchanged on September 1, 2024.
- Over the past year, RNAZ quarterly long term debt has dropped by -$189.80 thousand (-100.00%).
- RNAZ quarterly long term debt is now -100.00% below its all-time high of $2.13 million, reached on June 30, 2021.
Performance
RNAZ Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
RNAZ Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -100.0% |
| 3 y3 years | -98.2% | - |
| 5 y5 years | -95.9% | - |
RNAZ Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -100.0% | at low |
| 5 y | 5-year | -98.2% | -100.0% | -100.0% | at low |
| alltime | all time | -98.2% | -100.0% | -100.0% | at low |
TransCode Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(-100.0%) |
| Dec 2023 | $38.30 K | $38.30 K(-79.8%) |
| Sep 2023 | - | $189.80 K(-28.6%) |
| Jun 2023 | - | $265.70 K(-29.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $377.80 K(>+9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(-100.0%) |
| Jun 2021 | - | $2.13 M(+0.9%) |
| Mar 2021 | - | $2.11 M(+0.9%) |
| Dec 2020 | $2.09 M(+124.9%) | - |
| Dec 2020 | - | $2.09 M |
| Dec 2019 | $927.80 K | - |
FAQ
- What is TransCode Therapeutics annual long term debt?
- What is the all time high annual long term debt for TransCode Therapeutics?
- What is TransCode Therapeutics annual long term debt year-on-year change?
- What is TransCode Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly long term debt year-on-year change?
What is TransCode Therapeutics annual long term debt?
The current annual long term debt of RNAZ is $38.30 K
What is the all time high annual long term debt for TransCode Therapeutics?
TransCode Therapeutics all-time high annual long term debt is $2.09 M
What is TransCode Therapeutics annual long term debt year-on-year change?
Over the past year, RNAZ annual long term debt has changed by +$38.30 K (+100.00%)
What is TransCode Therapeutics quarterly long term debt?
The current quarterly long term debt of RNAZ is $0.00
What is the all time high quarterly long term debt for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly long term debt is $2.13 M
What is TransCode Therapeutics quarterly long term debt year-on-year change?
Over the past year, RNAZ quarterly long term debt has changed by -$189.80 K (-100.00%)